Swiss National Bank
BNGO icon

Swiss National Bank’s Bionano Genomics BNGO Stock Holding History

Swiss National Bank’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,068
Closed -$711K – 2612
2023
Q1 		$711K Sell
1,068
-100
-9% -$88.8K ﹤0.01% 2418
2022
Q4 		$1.02M Buy
1,168
+28
+2% +$35.2K ﹤0.01% 2331
2022
Q3 		$1.25M Hold
1,140
– – ﹤0.01% 2198
2022
Q2 		$944K Hold
1,140
– – ﹤0.01% 2398
2022
Q1 		$1.76M Buy
1,140
+116
+11% +$157K ﹤0.01% 2101
2021
Q4 		$1.84M Hold
1,024
– – ﹤0.01% 2124
2021
Q3 		$3.38M Hold
1,024
– – ﹤0.01% 1717
2021
Q2 		$4.5M Buy
+1,024
New +$4.04M ﹤0.01% 1572

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Swiss National Bank's BNGO Position: Q2 2023 in Review

Swiss National Bank sold out of Bionano Genomics (BNGO) in Q2 2023, closing a stake of 1,068 shares — an estimated $711K sold.

Swiss National Bank first reported a position in BNGO in Q2 2021 and held it in 8 quarters. The position peaked at $4.5M in Q2 2021. 108 funds tracked by Wall St. Rank hold BNGO as of Q2 2023.

  • Swiss National Bank reported no remaining Bionano Genomics position as of Q2 2023 after selling out during the quarter.
  • Swiss National Bank sold 1,068 Bionano Genomics shares in Q2 2023, an estimated $711K.
  • Swiss National Bank first reported a position in Bionano Genomics in Q2 2021 and held it in 8 quarters.
  • Swiss National Bank's Bionano Genomics position peaked at $4.5M in Q2 2021.
  • 108 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2023.

Based on Swiss National Bank's 13F filing for Q2 2023, filed 9 Aug 2023.